Famotidine Powder, For Suspension
Product Images NDC 31722-063

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 31722-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Famotidine-container-label-50ml (Famotidine Container Label 50ml)

Famotidine-container-label-50ml (Famotidine Container Label 50ml)
Label for Famotidine for Oral Suspension, USP 40 mg/5 mL powder for suspension manufactured by Camber Pharmaceuticals, Inc. The label states 400 mg total in 50 mL when reconstituted, for oral use only, with directions to shake well before each use. It includes storage instructions, a barcode, and manufacturer contact information.*
FDA Label Image

Famotidine-structure (Famotidine Structure)

Famotidine-structure (Famotidine Structure)
Chemical structure of famotidine, showing its molecular arrangement including sulfonamide, thioether, and guanidine functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.